Overview

A Phase III Clinical Study to Evaluate the Efficacy and Safety of GZR18 Injection in Adult Type 2 Diabetes Mellitus

Status:
NOT_YET_RECRUITING

Trial end date:
2026-12-11

Target enrollment:

Participant gender:

Summary

The main purpose of this study is to investigate the Efficacy and Safety of GZR18 Injection in Chinese Subjects with Type 2 Diabetes Mellitus and Poor Blood Glucose Control by Metformin Monotherapy or in Combination with Sodium-dependent Glucose Transporter 2 (SGLT2) Inhibitors or Sulfonylureas

Phase:

PHASE3

Details

Lead Sponsor:

Gan & Lee Pharmaceuticals.

Treatments:

semaglutide